PAA

2.63%

19.5¢ pharmaust limited

Ann: PharmAust Completes Share Purchase Plan, page-96

First 96 Last

Share
Profile

Follow
pi065509

1,073 Posts.

192

26/07/24

20:49

Post #: 74939103
Share

Originally posted by Jockthegreat ↑

"As most on here would know I wasn't a support of Roger either and when I dared to suggest that Roger was looking run down and it was time for him to move on a lot of here told me I was an idiot."

Agree somewhat. A few of us were quite vocal about views on Rogers tenure. Others were very supportive. This is the beauty of a forum where people have differing views, some you win some you lose. I would hope that in this new phase of PAA investors don't fall into the apathetic approach of old and are more actively involved in the direction of their investment and hold MT and BOD to account. They must deliver.

"I am still waiting on the new board to add shareholder value, to announce what the new direction is for PAA."

Concur somewhat with the value adding statement, although recall we were perpetually stuck at 8c prior to MT. In saying that there appears to be a lot more value to extract from current progress and results than where we are at now. I think MT and team may be struggling to regain lost ground...

To announce a new direction? Why would they do that? What new direction do you want? On one hand you want them to deliver value and 'hurry up' and here you are demanding a new direction. Surely you understand the current direction is very, very, clearly MND and other neurodegenerative diseases? The fastest way to value is to get something commercialised. The fastest path currently with most understood chance of success is MND on the Healey platform.

"As for working / proceeding as far as possible all I got to say to that is would hate to see them going any slower.3 months to write the trial procedure doesn't appear to be working fast, if this is the best Healey can do then maybe they should look elsewhere."

Do you know of any other platform trials that could offer the opportunity provided by Healey, that could prepare the procedure in under 3 months? Also do you know if 3 months is faster, slower or equal to industry norms regarding timeframe to prepare? I'm guessing the answer is no. You also realise by 'looking elsewhere' that this will adding significant duration and slow things even more?

Expand

Yes exactly and I a recall they already announced plan B, that was the adaptive phase 2/3 to be run in Aus/EU/US would have cost more taken longer and a lot more to manage, luckily it wasn’t required and plan A came through in the end.

PAA Price at posting: 20.5¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 12 more messages in this thread...

First 96 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $94.89M

Open	High	Low	Value	Volume
19.0¢	19.5¢	19.0¢	$58.40K	305.6K

Buyers (Bids)

No.	Vol.	Price($)
2	115000	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
19.5¢	86074	3

View Market Depth

No.	Vol.	Price($)
1	100000	0.190
8	156232	0.185
10	635662	0.180
10	482365	0.175
8	151233	0.170

Price($)	Vol.	No.
0.195	86074	3
0.200	256824	3
0.205	113150	5
0.210	333355	8
0.215	266995	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PAA (ASX) Chart

Ann: PharmAust Completes Share Purchase Plan, page-96

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PharmAust Completes Share Purchase Plan, page-96

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News